MEC90 for Supra-inguinal Fascia Iliaca Block Performed Under Ultrasound Guidance in Arthroscopic Knee Surgery
Minimum Effective Concentration (MEC90) for Supra-inguinal Fascia Iliaca Block Performed Under Ultrasound Guidance in Arthroscopic Knee Surgery
1 other identifier
interventional
65
1 country
1
Brief Summary
In this study, the minimum effective concentration required for supra-inguinal fascia iliaca block applied in patients undergoing arthroscopic knee surgery is aimed. The same volume will be used in all of the block applications in the study, and the local anesthetic concentration used will be determined by increasing or decreasing according to the success of the previous block. The primary goal of the study is block success.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2022
CompletedFirst Posted
Study publicly available on registry
June 7, 2022
CompletedStudy Start
First participant enrolled
June 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2023
CompletedFebruary 28, 2023
February 1, 2023
9 months
May 30, 2022
February 27, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Block Success
Block success will be evaluated on the post-operative period in the antrior and lateral of thigh using pinprick test.
at 6, 12, 24 hours
Secondary Outcomes (1)
Tramadol Consumption
24 hours
Study Arms (2)
SIFIB with concentration "A"
ACTIVE COMPARATORThe patients were placed in a supine position, and their skin was disinfected and draped. A linear ultrasonography probe was positioned parasagittally and slightly medially on the anterior superior iliac spine. The sartorius, iliacus, internal oblique muscles and deep circumflex iliac artery were visualized. A 80-mm peripheral nerve block needle was advanced, using the in-plane technique, from cranial to caudal until the tip was positioned between the internal oblique and iliacus muscles. Suprainguinal fascia iliaca block will be performed with concentration "A".
SIFIB with concentration "B"
ACTIVE COMPARATORThe patients were placed in a supine position, and their skin was disinfected and draped. A linear ultrasonography probe was positioned parasagittally and slightly medially on the anterior superior iliac spine. The sartorius, iliacus, internal oblique muscles and deep circumflex iliac artery were visualized. A 80-mm peripheral nerve block needle was advanced, using the in-plane technique, from cranial to caudal until the tip was positioned between the internal oblique and iliacus muscles.Suprainguinal fascia iliaca block performed with concentration "B"
Interventions
Fascial Plane Blocks
Eligibility Criteria
You may qualify if:
- Patients undergoing arthroscopic knee surgery under spinal anesthesia will be included in the study.
You may not qualify if:
- Conditions where regional anesthesia is contraindicated (coagulopathy, infection..)
- Patients who underwent general anesthesia for the surgical procedure
- Patients who do not want to be included in the study by not signing the voluntary consent form.
- Patients with advanced dementia, orientation-cooperation problems
- History of allergy to local anesthetic drugs
- Infection status at the injection site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Samsun Universitylead
- Samsun Education and Research Hospitalcollaborator
Study Sites (1)
Samsun University
Samsun, Turkey (Türkiye)
Related Publications (2)
Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991 Spring;15(1):47-50. doi: 10.1016/s0149-7634(05)80090-9.
PMID: 2052197BACKGROUNDDurham SD, Flournoy N, Rosenberger WF. A random walk rule for phase I clinical trials. Biometrics. 1997 Jun;53(2):745-60.
PMID: 9192462RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
SERKAN TULGAR, M.D.
CLINICAL CHIEF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- All blocks will be performed by the same experienced anesthetist to ensure block quality and homogeneity. The anesthetist applying the block will not take part in the patient follow-up, the independent assistant following the patient will be blinded to the study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2022
First Posted
June 7, 2022
Study Start
June 7, 2022
Primary Completion
February 27, 2023
Study Completion
February 27, 2023
Last Updated
February 28, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share